Search results for: "Novo Nordisk" (283 records) Ingredients CPhI: Delivering excellence at every step On 1 September 2015, FeF Chemicals changed its name to Novo Nordisk Pharmatech Design & Build Novo Nordisk to build a manufacturing plant in Iran Signs memorandum of understanding with the Food and Drug Administration of the Islamic Republic of Iran Novo Nordisk builds new raw material warehouse in Denmark New 17,000-pallet facility will handle all the company’s inbound raw materials in the country Novo Nordisk to acquire Calibrium and MB2 Acquisition expands Novo Nordisk’s portfolio of diabetes and obesity projects Design & Build Novo Nordisk plans US$2bn investment in new production facilities in US and Denmark To produce APIs for oral semaglutide plus other insulin products and handle tableting and packaging Novo Nordisk pays US$2m for access to Genmab technology Two Danish firms will develop bispecific antibodies not related to cancer Brian Hilberdink promoted to President of Novo Nordisk Canada He has been with the Denmark-headquartered insulin specialist for 20 years Kåre Schultz appointed as President and CEO of Lundbeck He joins the company on 20 May 2015 Kymab secures an additional US$50m in Series B funding Woodford Patient Capital Trust and Malin Corporation take total Series B financing at Kymab to $90m Novo Nordisk invests DKK1.5bn in new manufacturing facility in Denmark for haemophilia treatments Will create around 100 new production and engineering jobs You need to be a subscriber to read this article. Click here to find out more. Regulatory New NCEs focus on cancer and orphan diseases The number of NCEs approved in Europe increased again in 2014, with the spotlight on cancer drugs and treatments for unmet medical needs. Dr Sarah Houlton reviews the new... New manufacturing facility in Russia for Novo Nordisk Novo Nordisk has opened a new formulation and filling facility for the production of insulin Bristol-Myers Squibb signs licensing deal with Novo Nordisk For discovery research programme focused on autoimmune diseases Paul Thomas joins Aegate as Regional Business Development Manager UK & Ireland Formerly Head of Sales at Novo Nordisk EU pharma companies may be required to disclose side-effects data, says ECJ If they are challenged by patients who have had adverse effects after taking a medicine Media Pharma industry is doing more to improve access to medicine in developing countries But struggles to perform well in some aspects that matter, finds Access to Medicine Index Previous1…5678 (current)91011…18Next